Mascoma Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Mascoma Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.2K	Hold	120	–	–	0.01%	169
2026 Q1	$67.4K	Hold	120	–	–	0.01%	163
2025 Q4	$81.2K	Hold	120	–	–	0.02%	144
2025 Q3	$76.7K	Hold	120	–	–	0.02%	159
2025 Q2	$64.4K	Hold	120	–	–	0.01%	167
2025 Q1	$50.4K	Hold	120	–	–	0.01%	187
2024 Q4	$49.6K	Hold	120	–	–	0.01%	198
2024 Q3	$60.6K	Hold	120	–	–	0.02%	181
2024 Q2	$58.5K	Hold	120	–	–	0.02%	179
2024 Q1	$64.8K	Hold	120	–	–	0.02%	162
2023 Q4	$66.6K	Hold	120	–	–	0.02%	164
2023 Q3	$52.5K	Buy	+120	New	+$59.8K	0.02%	188
2022 Q4	–	Sell	-8	Closed	-$3K	–	645
2022 Q3	$3K	Sell	8 -8	-50%	-$2.94K	﹤0.01%	531
2022 Q2	$6K	Sell	16 -19	-54%	-$7.75K	﹤0.01%	480
2022 Q1	$19K	Buy	35 +3	+9%	+$1.58K	0.01%	374
2021 Q4	$21K	Buy	+32	New	+$20.1K	0.01%	323

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Mascoma Wealth Management's IDXX Position: Q2 2026 in Review

Mascoma Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 120 shares worth $63.2K. The position accounts for 0.01% of the portfolio, ranked #169.

Mascoma Wealth Management first reported a position in IDXX in Q4 2021 and has held it in 16 quarters since. The position peaked at $81.2K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Mascoma Wealth Management held 120 shares of Idexx Laboratories worth $63.2K as of Q2 2026.
Mascoma Wealth Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #169 holding.
Mascoma Wealth Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 16 quarters since.
Mascoma Wealth Management's Idexx Laboratories position peaked at $81.2K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.